Literature DB >> 24055222

First seizure in the older patient: clinical features and prognosis.

Nicholas Lawn1, Andrew Kelly, John Dunne, Judy Lee, Andrew Wesseldine.   

Abstract

PURPOSE: The prognosis of first seizure in the elderly has rarely been studied. Despite this, anti-epileptic drug treatment following first seizure is often recommended in older adults due to the perception that recurrence is inevitable and associated with significant morbidity. This study aims to establish whether older patients presenting with first-ever seizure are more likely to have a second seizure or not, and to examine their clinical features including seizure-related morbidity.
METHODS: Prospective observational study of adults seen by a hospital-based first seizure service between 2000 and 2011. The prognosis and clinical features of older (aged ≥65 years) and younger (aged 16-64 years) patients were compared. KEY
FINDINGS: 139 of 1008 patients with first-ever unprovoked seizure were aged ≥65 years (mean age 74 years). The majority of these older patients were healthy (95% ambulant, 81% Rankin score ≤2). The likelihood of a second seizure at one year was 53% (95% CI 45-62) in older patients and 48% (95% CI 44-51) in younger patients. Independent predictors of seizure recurrence were remote symptomatic etiology, first seizure arising from sleep, epileptiform abnormality on EEG and partial seizures but not age. Older patients were less likely to suffer a seizure-related injury with both the presenting seizure and the first recurrence.
CONCLUSIONS: With first-ever seizure age is not an independent predictor of seizure recurrence and older patients are less likely to sustain a seizure-related injury. Treatment decisions in older patients presenting with first-ever seizure should be based on established risk factors for seizure recurrence rather than age.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Elderly; First seizure; Prognosis; Seizure-related injury

Mesh:

Year:  2013        PMID: 24055222     DOI: 10.1016/j.eplepsyres.2013.08.009

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  New-onset epilepsy in the elderly.

Authors:  Lily Chi Vu; Loretta Piccenna; Patrick Kwan; Terence J O'Brien
Journal:  Br J Clin Pharmacol       Date:  2018-07-28       Impact factor: 4.335

Review 2.  Epilepsy in the Elderly: Treatment and Consideration of Comorbid Diseases.

Authors:  Sang Kun Lee
Journal:  J Epilepsy Res       Date:  2019-06-30

3.  Diagnostic Accuracy of the Ambulatory EEG vs. Routine EEG for First Single Unprovoked Seizures and Seizure Recurrence: The DX-Seizure Study.

Authors:  Lizbeth Hernández-Ronquillo; Lilian Thorpe; Dianne Dash; Tabrez Hussein; Gary Hunter; Karen Waterhouse; Pragma Laboni Roy; Jose F Téllez-Zenteno
Journal:  Front Neurol       Date:  2020-04-09       Impact factor: 4.003

4.  Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis.

Authors:  Elena Tartara; Elisa Micalizzi; Sofia Scanziani; Elena Ballante; Matteo Paoletti; Carlo Andrea Galimberti
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

5.  The Role of Antiepileptic Treatment in the Recurrence Rate of Seizures After First Attack: A Randomized Clinical Trial.

Authors:  Farhad Assarzadegan; Hanif Tabesh; Omid Hesami; Hojjat Derakhshanfar; Nahid Beladi Moghadam; Arya Shoghli; Andrew David Beale; Seyed-Mostafa Hosseini-Zijoud
Journal:  Iran J Child Neurol       Date:  2015

6.  Clinical course of poststroke epilepsy: a retrospective nested case-control study.

Authors:  Johan Zelano; Rebecca Gertz Lundberg; Leopold Baars; Emelie Hedegärd; Eva Kumlien
Journal:  Brain Behav       Date:  2015-07-22       Impact factor: 2.708

Review 7.  Managing Status Epilepticus in the Older Adult.

Authors:  Stephane Legriel; Gretchen M Brophy
Journal:  J Clin Med       Date:  2016-05-11       Impact factor: 4.241

8.  Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.

Authors:  Jonathan Vöglein; Ingrid Ricard; Soheyl Noachtar; Walter A Kukull; Marianne Dieterich; Johannes Levin; Adrian Danek
Journal:  J Neurol       Date:  2020-06-02       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.